Nvidia launches BioNeMo Agent Toolkit for life sciences AI agents
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/22/2026
- Wall Street indexes dip with technology earnings, rising oil in focus
- Google increases capex forecast again after cloud-driven quarterly beat
- As Musk pivots beyond cars, Tesla’s autos engine is under strain
- Oil settles up more than 3% to six-week high as Mideast conflict threatens oil transit routes
- Can Alphabet earnings reignite investor enthusiasm for the Magnificent Seven?
- Emirates refusing to take delivery of first 10 Boeing 777X jets
- Intersnack to acquire Utz Brands at $14.25 per share in go-private deal
- Crude Inventory Rose 2 Million Barrels Last Week - EIA
- Wall St ends higher on chip stocks recovery; earnings in focus
- Palo Alto Networks to acquire Embrace to expand observability tools
NVIDIA Announces BioNeMo Agent Toolkit — Tools for Agents to Accelerate Scientific Discovery
June 23, 2026 9:00 AM EDTNews Summary:
Industry and research leaders including Dassault Systèmes, Databricks, Lilly, OpenAI, Schrödinger, Snowflake, the UW Medicine Institute for Protein Design and dozens others are adopting, and Anthropic and OpenAI are integrating, NVIDIA BioNeMo Agent Toolkit to bring agentic life sciences workflows to researchers and scientists.NVIDIA BioNeMo Agent Toolkit including NVIDIA Nemotron, NemoClaw, OpenShell and BioNeMo gives agents accelerated life sciences tools spanning biology, chemistry, genomics and drug discovery.New NVIDIA BioNeMo tools give agents the context and know-how to execute scientific computing improving accuracy, task... More